Brief report: Increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice

Arthritis and Rheumatism

Volumn 65, Issue 3, 2013, Pages 764-769

  Ichinose, Kunihiro ^a   Zhang, Zheng ^a   Koga, Tomohiro ^a   Juang, Yuang Taung ^a   Kis Tõth, Katalin ^a   Sharpe, Arlene H ^b   Kuchroo, Vijay ^b   Crispín, José C ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; PROTEIN VARIANT;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BACKCROSSING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS VULGARIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLICING DEFECT; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CTLA-4 ANTIGEN; FEMALE; GENE EXPRESSION; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; RNA SPLICE SITES; T-LYMPHOCYTES, REGULATORY;

EID: 84874448203     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37790     Document Type: Article

References (15)

1. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-13.
2. Walunas TL, Bakker CY, Bluestone JA,. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-50.
3. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-10.
4. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH,. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-7.
5. Dariavach P, Mattei MG, Golstein P, Lefranc MP,. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988; 18: 1901-5.
6. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
7. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-60.
8. Hudson LL, Rocca K, Song YW, Pandey JP,. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 2002; 111: 452-5.
9. Lee YH, Harley JB, Nath SK,. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 2005; 116: 361-7.
10. Liu SM, Sutherland AP, Zhang Z, Rainbow DB, Quintana FJ, Paterson AM, et al. Overexpression of the CTLA-4 isoform lacking exons 2 and 3 causes autoimmunity. J Immunol 2012; 188: 155-62.
11. Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA,. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34: 2996-3005.
12. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5.
13. Liu MF, Liu HS, Wang CR, Lei HY,. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. J Clin Immunol 1998; 18: 392-8.
14. Hirashima M, Fukazawa T, Abe K, Morita Y, Kusaoi M, Hashimoto H,. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients. Lupus 2004; 13: 24-31.
15. Jury EC, Flores-Borja F, Kalsi HS, Lazarus M, Isenberg DA, Mauri C, et al. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol 2010; 40: 569-78.